Dr. Patel on Primary and Adaptive Resistance to Immunotherapy in NSCLC – OncLive
Dr. Patel on Primary and Adaptive Resistance to Immunotherapy in NSCLCOncLive… modalities to best determine which therapeutic strategy makes the most sense to inflame an otherwise cold tumor microenvironment will be key. This is one of the biggest ar… Continue reading
